J.W. Cole Advisors Inc. Sells 652 Shares of Colgate-Palmolive (NYSE:CL)

J.W. Cole Advisors Inc. decreased its holdings in Colgate-Palmolive (NYSE:CLGet Rating) by 10.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,855 shares of the company’s stock after selling 652 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Colgate-Palmolive were worth $444,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Bank of New Hampshire increased its position in Colgate-Palmolive by 0.5% during the 1st quarter. Bank of New Hampshire now owns 24,551 shares of the company’s stock valued at $1,862,000 after purchasing an additional 123 shares during the period. First Foundation Advisors grew its position in shares of Colgate-Palmolive by 4.5% in the 1st quarter. First Foundation Advisors now owns 3,152 shares of the company’s stock worth $239,000 after buying an additional 137 shares during the last quarter. Burney Co. grew its position in shares of Colgate-Palmolive by 0.9% in the 1st quarter. Burney Co. now owns 16,515 shares of the company’s stock worth $1,252,000 after buying an additional 140 shares during the last quarter. Siemens Fonds Invest GmbH grew its position in shares of Colgate-Palmolive by 1.3% in the 4th quarter. Siemens Fonds Invest GmbH now owns 11,444 shares of the company’s stock worth $968,000 after buying an additional 145 shares during the last quarter. Finally, Humankind Investments LLC grew its position in shares of Colgate-Palmolive by 1.8% in the 1st quarter. Humankind Investments LLC now owns 8,387 shares of the company’s stock worth $636,000 after buying an additional 146 shares during the last quarter. Institutional investors own 78.62% of the company’s stock.

Insider Activity at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 51,665 shares of the business’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $81.27, for a total value of $4,198,814.55. Following the completion of the sale, the chief executive officer now owns 221,790 shares of the company’s stock, valued at approximately $18,024,873.30. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, insider Jennifer Daniels sold 24,703 shares of the company’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $81.25, for a total transaction of $2,007,118.75. Following the completion of the sale, the insider now owns 48,163 shares of the company’s stock, valued at $3,913,243.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Noel R. Wallace sold 51,665 shares of the company’s stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $81.27, for a total transaction of $4,198,814.55. Following the sale, the chief executive officer now directly owns 221,790 shares of the company’s stock, valued at approximately $18,024,873.30. The disclosure for this sale can be found here. Insiders sold a total of 125,802 shares of company stock worth $10,100,532 in the last three months. Company insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CL. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Monday. Wells Fargo & Company upgraded shares of Colgate-Palmolive to an “equal weight” rating in a research note on Tuesday, August 9th. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $79.00 to $78.00 in a research note on Thursday, July 21st. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Colgate-Palmolive from $88.00 to $87.00 in a research note on Tuesday, July 19th. Finally, Barclays lifted their target price on shares of Colgate-Palmolive from $71.00 to $74.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 2nd. Thirteen research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $84.57.

Colgate-Palmolive Stock Performance

CL opened at $76.01 on Tuesday. The company has a debt-to-equity ratio of 14.26, a current ratio of 1.17 and a quick ratio of 0.72. The firm has a fifty day moving average price of $79.10 and a 200 day moving average price of $78.11. Colgate-Palmolive has a 1 year low of $72.20 and a 1 year high of $85.61. The stock has a market cap of $63.40 billion, a P/E ratio of 32.90, a P/E/G ratio of 5.42 and a beta of 0.48.

Colgate-Palmolive (NYSE:CLGet Rating) last posted its earnings results on Friday, July 29th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. Colgate-Palmolive had a net margin of 10.98% and a return on equity of 315.10%. The firm had revenue of $4.48 billion during the quarter, compared to analysts’ expectations of $4.35 billion. During the same period in the previous year, the business posted $0.80 EPS. The business’s revenue was up 5.3% compared to the same quarter last year. Equities research analysts anticipate that Colgate-Palmolive will post 3.03 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 15th. Investors of record on Friday, October 21st will be paid a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 2.47%. The ex-dividend date of this dividend is Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 81.39%.

Colgate-Palmolive Company Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.